CRISPR Therapeutics Stock (NASDAQ:CRSP), Quotes and News Summary

Q: What sector and industry does CRISPR Therapeutics (CRSP) operate in?

CRISPR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

CRISPR Therapeutics Stock (NASDAQ: CRSP) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	622.000 / 1.714M
Day Range	- - -
52 Wk Range	37.550 - 91.100
Market Cap	$4.839B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	19.72%
Days to Cover	12.19

Recent News

Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz

On Tuesday, Cathie Wood-led Ark Invest made a significant move by offloading a substantial number of shares in Coinbase Global Inc (NASDAQ:COIN), despite Bitcoin (CRYPTO: BTC) reaching new

Benzinga Neuro

Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices

Latest pharmaceutical trends in the U.S. as drug prices surged 35% in 2023. Uncover insights into the industry's focus on rare diseases, escalating costs, and the impact on FDA-approved drugs.

Vandana Singh

Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

2.8

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy CRISPR Therapeutics (CRSP) stock?

You can purchase shares of CRISPR Therapeutics (NASDAQ: CRSP) through any online brokerage.

View our list of the best stock brokerages.

Who are CRISPR Therapeutics's (CRSP) competitors?

There are no as such competitors for CRISPR Therapeutics.

What is the target price for CRISPR Therapeutics (CRSP) stock?

The latest price target for CRISPR Therapeutics (NASDAQ: CRSP) was reported by Citigroup on Thursday, April 18, 2024. The analyst firm set a price target for 89.00 expecting CRSP to rise to within 12 months (a possible 56.11% upside). 47 analyst firms have reported ratings in the last year.

Current Stock Price for CRISPR Therapeutics (CRSP)?

The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $57.01 last updated May 6, 2024 at 7:47 PM EDT.

Does CRISPR Therapeutics (CRSP) pay a dividend?

There are no upcoming dividends for CRISPR Therapeutics.

When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?

CRISPR Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.

Is CRISPR Therapeutics (CRSP) going to split?

There is no upcoming split for CRISPR Therapeutics.

What sector and industry does CRISPR Therapeutics (CRSP) operate in?

CRISPR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.